siRNA, Anti-TAF1A, 2'-F/2'-OMe/2'-MOE/Ribo/Backbone-modified(CAT#: SIRGT26716WQ-2OMe)

The product SIRGT26716WQ-2OMe is a type of small interfering RNA (siRNA) that targets TAF1A gene and regulates the expression of gene. The siRNA interferes with the expression of TAF1A gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001201536.1; NM_005681.3; NM_139352.2
Alternative Names MGC:17061; RAFI48; SL1; TAFI48
Related Diseases Familial Isolated Dilated Cardiomyopathy
Purification HPLC
Target Gene
Gene ID 9015
Uniprot ID Q15573
Sub Cat Target Species Modification Scale  
SIRGT27716WQ-2F TAF1A Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT28716WQ-2MOE TAF1A Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT26716WQ-RB TAF1A Human Ribo-modified Inquiry
SIRGT27716WQ-BB TAF1A Human Backbone-modified Inquiry

Related Products